Inventor · disambiguated record
Luigina Romani
Also filed as: ROMANI LUIGINA
11 granted patents·7 pending applications·11 citations·filing 2004–2022
84Inventor score
Files withSIGMA TAU IND FARMACEUTI4RASI GUIDO2SCICLONE PHARMACEUTICALS INT LTD2CARMINATI PAOLO1GARACI ENRICO1
Top patents by PatentIndex Score
18 records- 0182US11524056B2Thymosin alpha 1 for use in treatment of cystic fibrosisSCICLONE PHARMACEUTICALS INT LTD·Filed 2019·Granted Dec 13, 2022·1 cites·10 claims
- 0277US10478474B2Thymosin alpha 1 for use in treatment of cystic fibrosisSCICLONE PHARMACEUTICALS INT LTD·Filed 2016·Granted Nov 19, 2019·2 cites·10 claims
- 0376US8586035B2Use of IL-23 antagonists for treatment of infectionKOPF MANFRED·Filed 2008·Granted Nov 19, 2013·5 cites·12 claims
- 0474US12083165B2Thymosin alpha 1 for use in treatment of cystic fibrosisSCICLONE PHARMACEUTICALS INT SG PTE LTD·Filed 2022·Granted Sep 10, 2024·0 cites·12 claims
- 0565US7910092B2Use of the long pentraxin PTX3 for the prevention or treatment of viral diseasesTECNOGEN SPA·Filed 2007·Granted Mar 22, 2011·2 cites·2 claims
- 0653US8207294B2Treatment of Aspergillus infections with alpha thymosin peptidesRASI GUIDO·Filed 2004·Granted Jun 26, 2012·1 cites·12 claims
- 0752US2009270594A1Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergiesSIGMA TAU IND FARMACEUTI·Filed 2007·Application pending·0 cites
- 0851US2014296135A1Medicament for the treatment of fungal infections particularly aspergillosisSIGMA TAU IND FARMACEUTI·Filed 2014·Application pending·0 cites
- 0950US8022036B2Use of thymosin alpha 1 for the treatment of immunological diseasesSIGMA TAU IND FARMACEUTI·Filed 2008·Granted Sep 20, 2011·0 cites·14 claims
- 1049US2014147442A1Use of il-23 antagonists for treatment of infectionMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 1146US10751322B2Indole-3-aldehyde for treating dysreactive immune disordersUniversita′ degli Studi di Perugia·Filed 2014·Granted Aug 25, 2020·0 cites·3 claims
- 1246US2021077585A1Method of treatment of immune checkpoint inhibitor-related immune adverse effectsGARACI ENRICO·Filed 2020·Application pending·0 cites
- 1345US8337828B2Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infectionROMANI LUIGINA·Filed 2007·Granted Dec 25, 2012·0 cites·3 claims
- 1445US2022241378A1Compositions and methods for treatment of chronic granulomatous diseaseREGENERX BIOPHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1544US8389680B2Treatment of Aspergillus infections with alpha thymosin peptidesRASI GUIDO·Filed 2012·Granted Mar 5, 2013·0 cites·21 claims
- 1644US8268304B2Use of the long pentraxin PTX3 for the prevention or treatment of viral diseasesCARMINATI PAOLO·Filed 2011·Granted Sep 18, 2012·0 cites·4 claims
- 1743US2010004174A1Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseasesSIGMA TAU IND FARMACEUTI·Filed 2007·Application pending·0 cites
- 1838US2016008391A1GALACTOSAMINOGALACTAN COMPRISING alpha-1-4 LINKED GALACTOSE AND alpha-1-4 LINKED N-ACETYLGALACTOSAMINE FOR USE IN THE TREATMENT OF AT LEAST ONE INFLAMMATORY DISEASEPASTEUR INSTITUT·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Luigina Romani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →